Dashboard
1
Strong Long Term Fundamental Strength with an average Return on Equity (ROE) of 29.96%
- Healthy long term growth as Net Sales has grown by an annual rate of 12.48%
- Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 28.38
2
The company has declared Negative results for the last 5 consecutive quarters
3
With ROE of 13.23%, it has a expensive valuation with a 1.56 Price to Book Value
4
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Tour, Travel Related Services
SEK 341 Million (Micro Cap)
12.00
NA
5.54%
-0.32
13.81%
1.17
Revenue and Profits:
Net Sales:
352 Million
(Quarterly Results - Jun 2025)
Net Profit:
9 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-7.38%
0%
-7.38%
6 Months
-1.52%
0%
-1.52%
1 Year
-27.0%
0%
-27.0%
2 Years
-63.11%
0%
-63.11%
3 Years
-66.2%
0%
-66.2%
4 Years
-32.61%
0%
-32.61%
5 Years
13.8%
0%
13.8%
Dedicare AB for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
12.48%
EBIT Growth (5y)
-5.42%
EBIT to Interest (avg)
28.38
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.49
Sales to Capital Employed (avg)
5.45
Tax Ratio
20.44%
Dividend Payout Ratio
50.79%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
77.36%
ROE (avg)
29.96%
Valuation key factors
Factor
Value
P/E Ratio
12
Industry P/E
Price to Book Value
1.56
EV to EBIT
14.02
EV to EBITDA
7.01
EV to Capital Employed
1.85
EV to Sales
0.22
PEG Ratio
NA
Dividend Yield
4.28%
ROCE (Latest)
13.17%
ROE (Latest)
13.23%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
Jun'25
Mar'25
Change(%)
Net Sales
351.70
351.50
0.06%
Operating Profit (PBDIT) excl Other Income
12.80
10.30
24.27%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
9.10
6.90
31.88%
Operating Profit Margin (Excl OI)
21.00%
13.90%
0.71%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2025 is 0.06% vs -9.64% in Mar 2025
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2025 is 31.88% vs -52.41% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
1,703.90
1,949.40
-12.59%
Operating Profit (PBDIT) excl Other Income
53.30
130.20
-59.06%
Interest
5.10
7.20
-29.17%
Exceptional Items
0.00
-0.10
100.00%
Consolidate Net Profit
47.10
110.40
-57.34%
Operating Profit Margin (Excl OI)
16.80%
54.30%
-3.75%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -12.59% vs 11.29% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -57.34% vs 8.98% in Dec 2023
About Dedicare AB 
Dedicare AB
Tour, Travel Related Services
Dedicare publ AB is a Sweden-based company engaged in the employee leasing services. The Company is principally engaged in a recruitment of medical doctors, nurses and other health care workers in Sweden, Norway and Finland. Among the Company’s clients, there are 18 counties and 150 communities from Sweden and Norway and private companies. In November 2010, the Company launched its first care activity by setting up a Company Dedicare Omsorg AB. It provides support and personal assistance for people with disabilities. The Company has six wholly owned subsidiaries, including Dedicare AS, Dedicare Doctor AB, Dedicare OY, Dedicare Doctor AS, Dedicare Sales AB and Dedicare Omsorg AB. On 16 April 2015, the Company acquired Dedicare Assistanse AS.
Company Coordinates 
Company Details
Ringvagen 100 , STOCKHOLM None : 118 60
Registrar Details






